HealthCor Management »

Chinook Therapeutics shares owned by HealthCor Management

Quarter-by-quarter ownership of Chinook Therapeutics shares owned by HealthCor Management from 13F filings

Historical chart of HealthCor Management investment in Chinook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Chinook Therapeutics held by HealthCor Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chinook Therapeutics by HealthCor Management

Quarter filed Position value Share count Share price at filing
2022-12-31 $1.6M 60k 26.20
2022-09-30 $5.2M 267k 19.66

More positions owned by HealthCor Management

BioMarin Pharmaceutical (BMRN)
Dex (DXCM)
Cytokinetics Com New (CYTK)
Acrivon Therapeutics Common Stock (ACRV)
Hyperfine Com Cl A (HYPR)
Alkermes SHS (ALKS)
CONMED Corporation (CNMD)
Neurocrine Biosciences (NBIX)
Syndax Pharmaceuticals (SNDX)
Chinook Therapeutics
Intuitive Surgical Com New (ISRG)
Blueprint Medicines (BPMC)
Geron Corporation (GERN)
Penumbra (PEN)
Rocket Pharmaceuticals (RCKT)

View all positions for HealthCor Management

Top funds holding Chinook Therapeutics

Farther Finance Advisors
Parallel Advisors

View all funds holding Chinook Therapeutics